Injen Rx Pharma Limited - Company Profile

It is a chemicals public limited company based in Mumbai, Maharashtra, India, established in 2005.
2005 Mumbai, Maharashtra, India Under Liquidation
Last Updated:
Access Report
About Injen Rx Pharma Limited

Injen Rx Pharma Limited, a under liquidation public limited company, was established on 15 July 2005 in Mumbai, Maharashtra, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24230MH2005PLC154829. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.00 M and a paid-up capital of ₹1.37 M.

Its leadership includes Devesh Malladi (Director), Rajendra Prabhu Kamalakant (Director), Shobna Devesh Malladi (Director). Its latest AGM occurred on 08 September 2007, with the balance sheet filed on 31 March 2007. It is based at 501 Sentinelhirananadani Gardens Powai, Mumbai, Maharashtra, 400076.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230MH2005PLC154829

  • Registration Number

    154829

  • Incorporation Date

    15 July 2005

  • Authorized Capital

    ₹2.00 M

  • Paid-Up Capital

    ₹1.37 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Under Liquidation

Key Metrics
  • Authorised Capital ₹ 2.00 M
  • Paid Up Capital ₹ 1.37 M
  • Company Age 20 Year, 6 Months
  • Last Filing with ROC 31 Mar 2007
Company report

Injen Rx Pharma Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Injen Rx Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Injen Rx Pharma Limited?
Current Directors
Name Designation Appointment Date Status
Devesh Malladi Director 15 Jul 2005 Current
Rajendra Prabhu Kamalakant Director 15 Jul 2006 Current
Shobna Devesh Malladi Director 15 Jul 2005 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Injen Rx Pharma.

Enhance accessibility to Injen Rx Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Injen Rx Pharma revenue growth over time
Injen Rx Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Injen Rx Pharma?

Unlock access to Injen Rx Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Injen Rx Pharma?

Unlock and access historical data on people associated with Injen Rx Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Injen Rx Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Injen Rx Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Injen Rx Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Injen Rx Pharma Limited last Annual general meeting of members was held on 08 Sep 2007 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Injen Rx Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2007 with Roc Mumbai. was documented.

  • Director Appointment

    Progress on Rajendra Prabhu Kamalakant was appointed as a Director was appointed as a Director on 15 Jul 2006 & has been associated with this company since 19 years 6 months . was documented.

  • Director Appointment

    Progress on Devesh Malladi was appointed as a Director was appointed as a Director on 15 Jul 2005 & has been associated with this company since 20 years 6 months . was documented.

  • Director Appointment

    Progress on Shobna Devesh Malladi was appointed as a Director was appointed as a Director on 15 Jul 2005 & has been associated with this company since 20 years 6 months . was documented.

  • Company Incorporation

    Injen Rx Pharma Limited was registered on 15 Jul 2005 with Roc Mumbai & aged 20 years 6 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Injen Rx Pharma Limited?

The CIN of Injen Rx Pharma Limited is U24230MH2005PLC154829.

Where is Injen Rx Pharma Limited headquartered?

Injen Rx Pharma Limited is headquartered at 501 Sentinelhirananadani Gardens Powai, Mumbai, Maharashtra, 400076.

When was Injen Rx Pharma Limited incorporated?

Injen Rx Pharma Limited was incorporated on 15 July 2005.

Who are the current directors of Injen Rx Pharma Limited?

The current directors of Injen Rx Pharma Limited are

What is the primary industry of Injen Rx Pharma Limited?

The primary industry of Injen Rx Pharma Limited is Chemicals.

Is Injen Rx Pharma Limited a listed company?

Injen Rx Pharma Limited is unlisted.

What is the capital structure of Injen Rx Pharma Limited?

The authorized capital of Injen Rx Pharma Limited is ₹2.00 M, and the paid-up capital is ₹1.37 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available